Global Hepatitis A Vaccine Market Insights, Forecast to 2026

Global Hepatitis A Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market Segments
1.3 Key Hepatitis A Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application
1.5.2 Government Institution
1.5.3 Private Sector
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Hepatitis A Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Hepatitis A Vaccine Industry
1.6.1.1 Hepatitis A Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hepatitis A Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hepatitis A Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
2.1.1 Global Hepatitis A Vaccine Revenue 2015-2026
2.1.2 Global Hepatitis A Vaccine Sales 2015-2026
2.2 Hepatitis A Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Hepatitis A Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepatitis A Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hepatitis A Vaccine Competitor Landscape by Players
3.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Hepatitis A Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Hepatitis A Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Hepatitis A Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Hepatitis A Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Revenue in 2019
3.2.5 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepatitis A Vaccine Price by Manufacturers
3.4 Hepatitis A Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis A Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Hepatitis A Vaccine Market Size by Type (2015-2020)
4.1.1 Global Hepatitis A Vaccine Sales by Type (2015-2020)
4.1.2 Global Hepatitis A Vaccine Revenue by Type (2015-2020)
4.1.3 Hepatitis A Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepatitis A Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepatitis A Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis A Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Hepatitis A Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepatitis A Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Hepatitis A Vaccine Market Size by Application (2015-2020)
5.1.1 Global Hepatitis A Vaccine Sales by Application (2015-2020)
5.1.2 Global Hepatitis A Vaccine Revenue by Application (2015-2020)
5.1.3 Hepatitis A Vaccine Price by Application (2015-2020)
5.2 Hepatitis A Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepatitis A Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis A Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis A Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hepatitis A Vaccine by Country
6.1.1 North America Hepatitis A Vaccine Sales by Country
6.1.2 North America Hepatitis A Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepatitis A Vaccine Market Facts & Figures by Type
6.3 North America Hepatitis A Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Hepatitis A Vaccine by Country
7.1.1 Europe Hepatitis A Vaccine Sales by Country
7.1.2 Europe Hepatitis A Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis A Vaccine Market Facts & Figures by Type
7.3 Europe Hepatitis A Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hepatitis A Vaccine by Region
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Region
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hepatitis A Vaccine by Country
9.1.1 Latin America Hepatitis A Vaccine Sales by Country
9.1.2 Latin America Hepatitis A Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepatitis A Vaccine Market Facts & Figures by Type
9.3 Central & South America Hepatitis A Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis A Vaccine by Country
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Country
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Hepatitis A Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Hepatitis A Vaccine Products Offered
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Hepatitis A Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Sinovac
11.4.1 Sinovac Corporation Information
11.4.2 Sinovac Description, Business Overview and Total Revenue
11.4.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sinovac Hepatitis A Vaccine Products Offered
11.4.5 Sinovac Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Corporation Information
11.5.2 Zhejiang Pukang Description, Business Overview and Total Revenue
11.5.3 Zhejiang Pukang Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
11.5.5 Zhejiang Pukang Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Corporation Information
11.6.2 Changchun Institute of Biological Description, Business Overview and Total Revenue
11.6.3 Changchun Institute of Biological Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
11.6.5 Changchun Institute of Biological Recent Development
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Description, Business Overview and Total Revenue
11.7.3 KM Biologics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 KM Biologics Hepatitis A Vaccine Products Offered
11.7.5 KM Biologics Recent Development
11.8 IMBCA
11.8.1 IMBCA Corporation Information
11.8.2 IMBCA Description, Business Overview and Total Revenue
11.8.3 IMBCA Sales, Revenue and Gross Margin (2015-2020)
11.8.4 IMBCA Hepatitis A Vaccine Products Offered
11.8.5 IMBCA Recent Development
11.9 ChangSheng
11.9.1 ChangSheng Corporation Information
11.9.2 ChangSheng Description, Business Overview and Total Revenue
11.9.3 ChangSheng Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ChangSheng Hepatitis A Vaccine Products Offered
11.9.5 ChangSheng Recent Development
11.10 Convac
11.10.1 Convac Corporation Information
11.10.2 Convac Description, Business Overview and Total Revenue
11.10.3 Convac Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Convac Hepatitis A Vaccine Products Offered
11.10.5 Convac Recent Development
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Hepatitis A Vaccine Products Offered
11.1.5 GSK Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepatitis A Vaccine Market Estimates and Projections by Region
12.1.1 Global Hepatitis A Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Hepatitis A Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Hepatitis A Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Hepatitis A Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Hepatitis A Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Hepatitis A Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Hepatitis A Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Hepatitis A Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Hepatitis A Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Hepatitis A Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepatitis A Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepatitis A Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepatitis A Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepatitis A Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepatitis A Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepatitis A Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Hepatitis A Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepatitis A Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepatitis A Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepatitis A Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepatitis A Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepatitis A Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hepatitis A Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis A Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Hepatitis A Vaccine Market Segments
Table 2. Ranking of Global Top Hepatitis A Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis A Vaccine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Inactivated Vaccine
Table 5. Major Manufacturers of Live Attenuated Vaccine
Table 6. COVID-19 Impact Global Market: (Four Hepatitis A Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Hepatitis A Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Hepatitis A Vaccine Players to Combat Covid-19 Impact
Table 11. Global Hepatitis A Vaccine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Hepatitis A Vaccine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Hepatitis A Vaccine Sales by Regions 2015-2020 (K MT)
Table 14. Global Hepatitis A Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Hepatitis A Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Hepatitis A Vaccine Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Hepatitis A Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2019)
Table 20. Hepatitis A Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Hepatitis A Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Hepatitis A Vaccine Price (2015-2020) (USD/MT)
Table 23. Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Hepatitis A Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 28. Global Hepatitis A Vaccine Sales Share by Type (2015-2020)
Table 29. Global Hepatitis A Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Hepatitis A Vaccine Revenue Share by Type (2015-2020)
Table 31. Hepatitis A Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 33. Global Hepatitis A Vaccine Sales Share by Application (2015-2020)
Table 34. North America Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 35. North America Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 39. North America Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 41. North America Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 43. Europe Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 47. Europe Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 49. Europe Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Hepatitis A Vaccine Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Hepatitis A Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 59. Latin America Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 63. Latin America Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 65. Latin America Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hepatitis A Vaccine Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Hepatitis A Vaccine Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 74. GSK Corporation Information
Table 75. GSK Description and Major Businesses
Table 76. GSK Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. GSK Product
Table 78. GSK Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Sinovac Corporation Information
Table 90. Sinovac Description and Major Businesses
Table 91. Sinovac Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sinovac Product
Table 93. Sinovac Recent Development
Table 94. Zhejiang Pukang Corporation Information
Table 95. Zhejiang Pukang Description and Major Businesses
Table 96. Zhejiang Pukang Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Zhejiang Pukang Product
Table 98. Zhejiang Pukang Recent Development
Table 99. Changchun Institute of Biological Corporation Information
Table 100. Changchun Institute of Biological Description and Major Businesses
Table 101. Changchun Institute of Biological Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Changchun Institute of Biological Product
Table 103. Changchun Institute of Biological Recent Development
Table 104. KM Biologics Corporation Information
Table 105. KM Biologics Description and Major Businesses
Table 106. KM Biologics Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. KM Biologics Product
Table 108. KM Biologics Recent Development
Table 109. IMBCA Corporation Information
Table 110. IMBCA Description and Major Businesses
Table 111. IMBCA Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. IMBCA Product
Table 113. IMBCA Recent Development
Table 114. ChangSheng Corporation Information
Table 115. ChangSheng Description and Major Businesses
Table 116. ChangSheng Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. ChangSheng Product
Table 118. ChangSheng Recent Development
Table 119. Convac Corporation Information
Table 120. Convac Description and Major Businesses
Table 121. Convac Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Convac Product
Table 123. Convac Recent Development
Table 124. Global Hepatitis A Vaccine Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Hepatitis A Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Hepatitis A Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Hepatitis A Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Hepatitis A Vaccine Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Hepatitis A Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Hepatitis A Vaccine Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Hepatitis A Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Hepatitis A Vaccine Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Hepatitis A Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Hepatitis A Vaccine Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Hepatitis A Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Hepatitis A Vaccine Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Hepatitis A Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Hepatitis A Vaccine Players
Table 142. Hepatitis A Vaccine Customers List
Table 143. Hepatitis A Vaccine Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Hepatitis A Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Hepatitis A Vaccine Report Years Considered
Figure 10. Global Hepatitis A Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Hepatitis A Vaccine Sales 2015-2026 (K MT)
Figure 12. Global Hepatitis A Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Hepatitis A Vaccine Sales Market Share by Region in 2019
Figure 15. Global Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Hepatitis A Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Hepatitis A Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Hepatitis A Vaccine Revenue in 2019
Figure 19. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 22. Global Hepatitis A Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Hepatitis A Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Hepatitis A Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 27. Global Hepatitis A Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Hepatitis A Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Hepatitis A Vaccine Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Hepatitis A Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 32. North America Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Hepatitis A Vaccine Market Share by Type in 2019
Figure 38. North America Hepatitis A Vaccine Market Share by Application in 2019
Figure 39. Europe Hepatitis A Vaccine Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Hepatitis A Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Hepatitis A Vaccine Market Share by Type in 2019
Figure 54. Europe Hepatitis A Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Hepatitis A Vaccine Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Hepatitis A Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region in 2019
Figure 59. China Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Hepatitis A Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Hepatitis A Vaccine Market Share by Application in 2019
Figure 83. Latin America Hepatitis A Vaccine Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Hepatitis A Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Hepatitis A Vaccine Market Share by Type in 2019
Figure 94. Latin America Hepatitis A Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Hepatitis A Vaccine Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 104. UAE Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Hepatitis A Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Hepatitis A Vaccine Market Share by Application in 2019
Figure 107. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Zhejiang Pukang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Changchun Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. KM Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. ChangSheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Convac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Hepatitis A Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America Hepatitis A Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Hepatitis A Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe Hepatitis A Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Hepatitis A Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific Hepatitis A Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Hepatitis A Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America Hepatitis A Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Hepatitis A Vaccine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hepatitis A Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89

According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......

Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......

Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......

Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Thymosin a1 Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Hepatitis B Immune Globulin Market Research Report 2023

Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......

Global Sofosbuvir Market Research Report 2023

Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......

Global Hepatitis A Vaccine Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs